Vestibular System in Migrainous Vertigo Patients

NCT ID: NCT00901953

Last Updated: 2009-05-15

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

65 participants

Study Classification

OBSERVATIONAL

Study Start Date

2007-05-31

Study Completion Date

2009-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Do migrainous vertigo patients have more pathology in their vestibular system than migraine patients without vertigo?

The aim of this study is to compare the vestibular system of migraine patients with and without vertigo in the symptom-free period by vestibular function tests, videonystagmography, vestibular evoked myogenic potentials, and subjective visual vertical.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Migraine Disorders Migraine Variant Episodic Recurrent Vertigo

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1

migrainous vertigo

No interventions assigned to this group

2

migraine without vertigo

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* migraine according to IHS criteria
* migrainous vertigo according to the Neuhauser-criteria

Exclusion Criteria

* no history of other neurological, vestibular, opthalmologic and ENT disorders
* no medications that could possibly influence test results
* intact hearing measured by audiometry
* pregnancy
Minimum Eligible Age

16 Years

Maximum Eligible Age

61 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Sorlandet Hospital HF

OTHER_GOV

Sponsor Role collaborator

University of Bergen

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Departement of Neurology, Sørlandet Hospital HF , Kristiansand, Norway

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Åse Mygland, PhD

Role: PRINCIPAL_INVESTIGATOR

Institute of clinical medicine, university of Bergen, Norway

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Dept. of neurology, Sørlandet Hospital HF

Kristiansand, Kristiansand, Norway

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Norway

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2.2006.3376

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.